文献速递膀胱癌与上尿路尿路上皮癌

机器人辅助根治性膀胱切除术联合完全腔内尿流改道与开放根治性膀胱切除术:一项随机对照试验的3年结局

Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial.
PubMed 文献 · Eur Urol · 2024-02-08

这项随机对照试验纳入116例拟行根治性膀胱切除术的患者,比较开放根治性膀胱切除术与机器人辅助根治性膀胱切除术联合完全腔内尿流改道的3年结局。机器人辅助手术组围手术期输血率显著更低(绝对风险降低19%,95%CI 2-36%,p=0.046),并发症率和3年肿瘤学结局两组无差异,机器人辅助组身体形象显著更好,但费用更高。

要点

  • 机器人辅助根治性膀胱切除术联合完全腔内尿流改道可安全实施,围手术期输血率较开放手术降低50%。
  • 两组围手术期和术后并发症率及3年肿瘤学结局无差异。
  • 机器人辅助组身体形象显著更好,但费用更高;日间和夜间控尿恢复概率两组无差异。

核心结论

  • 研究结果支持机器人辅助根治性膀胱切除术联合完全腔内尿流改道作为安全的手术选择,输血率降低50%,并发症率和3年肿瘤学结局与开放手术相当。
  • 机器人辅助手术的微创特性体现在该队列中更好的身体形象感知,日间和夜间控尿恢复概率两组相当,较高费用仍是机器人手术的缺点。

研究设计与样本

  • 随机对照试验,纳入cT2-4 N0 M0或卡介苗治疗失败的高级别非肌层浸润性尿路上皮癌、适合根治性膀胱切除术且无机器人手术绝对禁忌证的患者,共116例。
  • 采用基于体重指数、美国麻醉医师协会评分、术前血红蛋白、尿流改道类型、新辅助化疗和cT分期的协变量自适应随机化过程。
  • 主要终点为探究机器人辅助根治性膀胱切除术联合完全腔内尿流改道在输血率降低50%方面的优效性。
  • 次要结局包括早期康复方案依从性、围手术期和术后结局、再入院和并发症率、费用分析以及功能性、肿瘤学和生活质量结局。

主要发现

  • 主要终点得到证实,机器人辅助根治性膀胱切除术联合完全腔内尿流改道队列的总体围手术期输血率显著更低,绝对风险降低19%(95%置信区间2-36%;p=0.046)。
  • 两组围手术期和术后并发症及3年肿瘤学结局无差异。
  • 尽管开放根治性膀胱切除术在夜间尿垫使用定量分析上具有优效性,但日间和夜间控尿恢复概率无差异。
  • 机器人辅助根治性膀胱切除术联合完全腔内尿流改道队列的身体形象显著更好。
  • 费用分析证实机器人辅助根治性膀胱切除术是更昂贵的手术方式。

临床怎么用

  • 原文结论支持机器人辅助根治性膀胱切除术联合完全腔内尿流改道作为安全的手术选择,输血率降低50%,并发症率和3年肿瘤学结局与开放根治性膀胱切除术相当。
  • 机器人辅助根治性膀胱切除术的微创特性反映在该队列中更好的身体形象感知,日间和夜间控尿恢复概率两组相当。
  • 较高费用仍是机器人手术的缺点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Randomised controlled trials (RCTs) comparing open radical cystectomy (ORC) and robot-assisted RC (RARC) have involved an extracorporeal approach for urinary diversion (UD), undermining the potential benefits of a totally robotic procedure. Our objective was to compare 3-yr outcomes from a RCT comparing ORC to RARC with totally intracorporeal UD (iUD). METHODS: Patients with cT2-4 N0 M0 or bacillus Calmette-Guérin-failed high-grade non-muscle-invasive urothelial carcinoma who were candidates for RC without absolute contraindications to robotic surgery were included. A covariate adaptive randomisation process based on body mass index, American Society of Anesthesiologists score, preoperative haemoglobin, type of UD, neoadjuvant chemotherapy, and cT stage was used. The primary endpoint was to investigate the superiority of RARC with iUD in terms of a 50% reduction in transfusion rate. Secondary outcomes included adherence to an early recovery after surgery protocol, perioperative and postoperative outcomes, readmission and complication rates, a cost analysis, and functional, oncological, and health-related quality-of-life outcomes. KEY FINDINGS AND LIMITATIONS: Overall, 116 patients were enrolled. The primary endpoint was confirmed, as the overall perioperative transfusion rate was significantly lower in the RARC cohort, with an absolute risk reduction of 19% (95% confidence interval 2-36%; p = 0.046). No differences in perioperative and postoperative complications and 3-yr oncological outcomes were observed between the groups. Despite the superiority of ORC on quantitative analysis of night-time pad use, there were no differences in the probabilities of recovery of daytime and night-time continence. Body image was significantly better in the RARC cohort. Cost analysis confirmed that RARC is a more expensive surgical procedure. CONCLUSIONS AND CLINICAL IMPLICATIONS: Our findings support RARC with iUD as a safe surgical option; the transfusion rate was reduced by 50% and the complication rates and 3-yr oncological outcomes were comparable to those with ORC. The minimally invasive nature of RARC was reflected in better body image perception in this cohort. The probabilities of daytime and night-time continence recovery were comparable between the groups. Higher costs remain a drawback of robotic surgery. PATIENT SUMMARY: This RCT demonstrated a 50% transfusions rate's reduction compared to ORC. We confirmed safety and feasibility of RARC with i-UD providing comparable peri- and postoperative complication rates, as well as, 3yr oncologic outcomes to those of ORC. Patients receiving either RARC-iUD or ORC had comparable probabilities of urinary continence recovery after surgery.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Mastroianni R, Tuderti G, Ferriero M, et al. Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial. Eur Urol. 2024. PMID: 38336579. doi:10.1016/j.eururo.2024.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。